Skip to main content
Fig. 12 | Journal of Nanobiotechnology

Fig. 12

From: Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma

Fig. 12

The biocompatibility of AR-NADR in vivo. A Representative H&E-stained images of the major organs (heart, liver, spleen, lung, and kidney) harvested from mice at 14 days after various treatments (PBS, AR-NA, AR-NAR, DDP, AR-NAD, and AR-NADR). B Values of hematological parameters assayed upon various treatments. (a) RBC, (b) WBC, (c) Hb and (d) PLT. Scale bar: 50 μm. Data are presented as the means ± SD (n = 3)

Back to article page